Shilpa D Kadam8 Estates Ct APT 5202, Baltimore, MD 21208

Shilpa Kadam Phones & Addresses

8 Estates Ct APT 5202, Pikesville, MD 21208 (443) 759-8294

500 University Ave, Baltimore, MD 21210 (410) 759-8294 (443) 759-8294

Salt Lake City, UT

Fort Collins, CO

Work

Position: Clerical/White Collar

Education

Degree: Associate degree or higher

Mentions for Shilpa D Kadam

Resumes & CV records

Resumes

Shilpa Kadam Photo 28

Associate Professor

Location:
Baltimore, MD
Industry:
Hospital & Health Care
Work:
Johns Hopkins Medicine
Associate Professor
Johns Hopkins School of Medicine Nov 2012 - Feb 2019
Assistant Professor
Kennedy Krieger Institute Nov 2012 - Feb 2019
Faculty
Johns Hopkins School of Medicine Feb 2007 - Nov 2008
Department of Neurology
Colorado State University 2001 - 2006
Phd
Pune Institute of Neurology 1998 - 2001
Resident Doctor
Education:
Colorado State University 2001 - 2006
Doctorates, Doctor of Philosophy, Neuroscience
Department of Technology, Savitribai Phule Pune University
Fergusson College
Skills:
Neuroscience, Animal Models, Electrophysiology, Cell Biology, Immunohistochemistry, Molecular Biology, Microscopy, Research, In Vivo, Fluorescence Microscopy, Cell Culture, Life Sciences, Physiology, Confocal Microscopy, Stem Cells, Western Blotting, Neurology, Science, Clinical Research, Biochemistry, Translational Research
Languages:
Hindi
Marathi
English
Shilpa Kadam Photo 29

Shilpa Kadam

Industry:
Computer Software
Education:
University of Mumbai 1994 - 1998
Skills:
Project Management, Business Analysis, Agile Methodologies, Requirements Analysis, Sdlc, Scrum, Erp, Visio, Sql
Shilpa Kadam Photo 30

Shilpa Kadam

Shilpa Kadam Photo 31

Shilpa Kadam

Shilpa Kadam Photo 32

Shilpa Kadam

Location:
United States

Publications & IP owners

Us Patents

Compositions And Methods For Treating Refractory Seizures

US Patent:
2017028, Oct 5, 2017
Filed:
Aug 14, 2015
Appl. No.:
15/504141
Inventors:
- Baltimore MD, US
Shilpa D. Kadam - Pikesville MD, US
International Classification:
A61K 31/196
A61K 31/515
A61K 31/501
A61K 31/4166
Abstract:
The present invention relates to the field of seizures. More specifically, the present invention provides compositions and methods for treating refractory seizures in neonates. In one embodiment, the method comprises the steps of (a) administering to the patient an amount of a KCC2 agonist and/or trkB antagonist effective to restore KCC2 expression to normal physiological levels; and (b) administering to the patient an effective amount of an anti-seizure medication.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.